Drugs Made In America Acquisition II Stock (NASDAQ:DMII)


OwnershipFinancialsChart

Previous Close

$9.95

52W Range

$9.86 - $10.01

50D Avg

$9.96

200D Avg

$9.94

Market Cap

$523.04M

Avg Vol (3M)

$120.56K

Beta

-

Div Yield

-

DMII Company Profile


Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.

Show More

Industry

Shell Companies

Sector

Financial Services

Exchange

NASDAQ

ADR

-

Country

US

Employees

-

IPO Date

Dec 04, 2025

Website

DMII Performance


DMII Financial Summary


Dec 24
Revenue-
Operating Income$-151.72K
Net Income$-151.72K
EBITDA$-151.72K
Basic EPS-
Diluted EPS-

Fiscal year ends in Dec 24 | Currency in USD